Doublle Bioproduct Inc Report issue

For profit Phase 1 Phase 2
Founded: Guangzhou China (2001)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2005
NCT00262327
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

e10a (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Phase 1 Trials (2)

endostatin (endostar) (1 trial)

endostatin adenovirus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Head and Neck Neoplasms (Phase 2)

Nasopharyngeal Carcinoma (Phase 2)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5